Skip to main content
. 2018 Oct 23;115(4):752–764. doi: 10.1093/cvr/cvy257

Figure 6.

Figure 6

Selection of LEAF trial18 participants. HFrEF patients were compared with non-failing ‘control’ individuals (EF ≥50%) who were without a detectable myocardial infarction at 6 weeks of follow-up.